Objectives: The risk of adverse drug reactions (ADRs) increases with the nu
mber of drugs used. Most studies refer to potential interactions; the resul
ts regarding the severity of occurring and registered ADRs are inconsistent
. Therefore, we examined the relevance of drug-induced problems in the elde
rly in general practice and their association with polypharmacy.
Design: Retrospective cross-sectional analysis of prospectively collected d
ata. Setting: Three family practices participating in the medication and mo
rbidity Registration Network Groningen (RNG).
Methods: From 2185 elderly patients (>64 years) medication and morbidity da
ta were collected over the period of 2 years (1994 and 1995). Polypharmacy
was defined as the long-term simultaneous use of two or more drugs. Adverse
reactions recognised as such were coded as a separate 'diagnosis' A85. The
most risky drug groups and the most prevalent diseases in relation to ADRs
were studied.
Results: The incidence of ADRs in general practice was 5.7 per 100 elderly
patients and the prevalence 6.1 per 100. Moderate polypharmacy was more fre
quent in the elderly who experienced adverse effects; no other differences
in degree of polypharmacy could be found. The elderly who experienced adver
se reactions used overall more different drugs (14.4 +/- 7.6, of which 1.5
+/- 1.5 were used long term) than the other elderly patients (8.1 +/- 5.7,
of which 1.0 +/- 1.5 were long term). The incidence of ADRs increased non-s
ignificantly with the number of drugs used long term. Antibiotics, anti- hy
pertensives and non-steroidal anti-inflammatory drugs were mainly responsib
le for gastrointestinal complaints (nausea, diarrhoea and stomach pain) and
rash. In the cases of treating urinary tract infections and sleeping disor
ders: there was a significantly high risk of ADRs. Slightly more at risk fo
r adverse drug reactions were older patients with coronary heart disease or
asthma/chronic obstructive pulmonary disease.
Conclusion: Most of the ADRs observed in general practice turn out to be ra
ther harmless. This is in agreement with outpatient studies, though not wit
h hospital studies. An increased risk of adverse effects with the number of
drugs used simultaneously, as reported in other studies, was not confirmed
in our study. This study however is limited to actually registered effects
.